RESUMO
Aim: To assess the effect of bariatric surgery on the lean mass of women after one year of the procedure, comparing its outcomes upon the classification from both the Foundation of the National Institutes of Health (FNIH) and the European Working Group on Sarcopenia in the Elderly People (EWGSOP). Material and methods: Twenty-eight obese women aged 40.5 ± 9.8 yrs who underwent Roux-en-Y gastric bypass (RYGB) were included. 27 of them were reassessed after 6 months of surgery, and 16 completed the one-year follow-up. Pre-sarcopenia condition was assessed through a handgrip strength test and body composition by dual-energy X-ray absorptiometry (DXA). Total body mass, body mass index, and lean mass (LM) were collected prior to, 6 and 12 months after RYGB surgery. Results: All subjects reassessed after 12 months were diagnosed with pre-sarcopenia according to the FNIH classification criteria, while according to the EWGSOP2 Consensus they presented normal values. LM represented 14% of the influence on handgrip strength (p = .049) after 6 months of surgery; however, its influence on strength after 12 months increased to 30% (p = .028). Conclusion: The FNIH classification is the most effective criteria since it uses LM content as the first test, considering that strength capacity needs more time to be affected by the surgical procedure. On the other hand, the EWGSOP2 classification should not be applied to determine the loss of LM in younger populations regardless of what may have caused such changes.
Assuntos
Derivação Gástrica , Sarcopenia , Idoso , Feminino , Humanos , Estados Unidos , Sarcopenia/diagnóstico por imagem , Sarcopenia/etiologia , Força da Mão , Absorciometria de Fóton/efeitos adversos , Derivação Gástrica/efeitos adversos , National Institutes of Health (U.S.) , PrevalênciaRESUMO
OBJECTIVES: To assess the relationship between postural changes, osteoarthritis (OA) and bone mineral density (BMD) in postmenopausal women. METHODS: A total of 127 Brazilian women, aged 45 years or older, were included in this retrospective study. Subjects were divided in two groups: study group with postural changes (SG) and control group without postural changes (CG). Possible postural changes considered were scoliosis, kyphosis and lordosis. All women underwent BMD assessment and OA was identified at the region of the hip and lumbar spine by dual energy X-ray absorptiometry (DXA) analysis. RESULTS: SG was older (66.0 ± 7.3 years) than the CG (61.0 ± 8.6 years). In the entire sample we found thirteen women with OA and low BMD. Overall, the lumbar spine area was more affected by OA than the hip. The value of BMD T-score accounted for up to 77% of the changes observed in the SG group. CONCLUSION: Postural changes identified in women are directly related to aging and associated with bone loss and joint degeneration. Postural changes may be the primary sign of frailty as a result of body adaptation to pain related to musculoskeletal diseases.
Assuntos
Doenças Ósseas Metabólicas , Osteoartrite , Osteoporose Pós-Menopausa , Feminino , Humanos , Densidade Óssea , Estudos Retrospectivos , Pós-Menopausa , Osteoartrite/diagnóstico por imagem , Absorciometria de Fóton , Vértebras Lombares/diagnóstico por imagem , Osteoporose Pós-Menopausa/diagnóstico por imagemRESUMO
AIM: To analyze the influence of body components on bone mineral density (BMD) in women from perimenopause to old age. MATERIAL AND METHODS: A total of 117 women were allocated into three groups according to the reproductive stage (STRAW): perimenopausal (PEM, N = 28, mean age 44.8 ± 3.6), early postmenopausal (EPM, N = 36, mean age 51.4 ± 2.8) and late postmenopausal (LPM, N = 53; mean age 64.0 ± 1.7). Total body mass, body mass index (BMI), lean mass (LM), fat mass (FM), fat percentage (FP) and BMD at the lumbar spine (lBMD) and femoral neck (fBMD) were assessed. RESULTS: BMI, FM, LM and BMD values decreased from PEM to LPM. The total effect of FM on fBMD and lBMD was of 42% and 8% for PEM, 28% and 33% for EMP and 9% and 1% for LPM respectively. Additionally, the total effect of LM on fBMD and lBMD was 48% and 3% for PEM, 54% and 53% for EMP and 9% and 11% for LPM women respectively. CONCLUSION: BMI, LM, and FM decreased with aging. All these components had great influence on both fBMD and lBMD in EMP women. Conversely, in PEM these parameters only had influence on femoral BMD, but not on lumbar spine. These data suggests that LM is the most important component in BMD for women older than 50 years old, particularly in the hip.
Assuntos
Envelhecimento/fisiologia , Antropometria , Densidade Óssea/fisiologia , Perimenopausa/fisiologia , Pós-Menopausa/fisiologia , Adulto , Idoso , Composição Corporal/fisiologia , Índice de Massa Corporal , Feminino , Colo do Fêmur , Humanos , Vértebras Lombares , Pessoa de Meia-Idade , Magreza/fisiopatologiaRESUMO
Aim: To analyze the effects of body weight loss on bone mineral density (BMD) on hip (Hip BMD) and lumbar spine (Lumbar BMD) after six months of bariatric surgery. Bariatric surgery is an effective treatment for morbid obesity. Nonetheless, there are scant data on the effect of weight bearing on bone structure.Material and methods: Seventeen obese women aged 41.2 ± 11.3 yrs. who underwent Roux-en-Y gastric bypass (RYGB) were included. Body composition assessments were performed through dual-energy X-ray absorptiometry immediately before and after 6-months RYGB. Data collected pre- and post-RYGB included total body weight, body mass index (BMI), lean body mass (LM), fat mass (FM) and bone mineral content. The pre- (PRE) and post-operative (POST) results were compared.Results: Lumbar BMD POST presented a non-significant loss of 1.8% whereas Hip BMD POST showed a significant loss of 17.8%. The analysis demonstrated that BMI and LM PRE explained 26% and 49%, respectively, of Hip BMD PRE variability. In addition, LM POST explained 30% of hip BMD POST variability and was not significant for Lumbar BMD POST.Conclusions: Obesity and rapid weight loss showed direct influence in Hip BMD after six months of bariatric surgery. However, its effect on the lumbar spine area was smaller due to the higher capacity of the spine to dissipate loads through its curvature.
Assuntos
Cirurgia Bariátrica/efeitos adversos , Composição Corporal/fisiologia , Densidade Óssea/fisiologia , Obesidade Mórbida/cirurgia , Absorciometria de Fóton , Adulto , Cirurgia Bariátrica/estatística & dados numéricos , Índice de Massa Corporal , Brasil/epidemiologia , Feminino , Seguimentos , Derivação Gástrica/efeitos adversos , Derivação Gástrica/estatística & dados numéricos , Quadril , Humanos , Estudos Longitudinais , Vértebras Lombares , Pessoa de Meia-Idade , Obesidade Mórbida/epidemiologia , Obesidade Mórbida/metabolismo , Complicações Pós-Operatórias/epidemiologia , Complicações Pós-Operatórias/etiologia , Resultado do TratamentoRESUMO
Sleep disorders, resulting from hormonal changes and vasomotor symptoms, are common in both peri- and postmenopausal women. Poor sleep quality is associated with increased metabolic and cardiovascular risk, depression and a global impairment in health status. OBJECTIVES: Our study aimed to assess sleep quality in a sample of postmenopausal women and to identify the factors associated with poor sleep quality. It also considered the negative impact of sleep disorders such as insomnia, hypersomnia and breathing disturbances. SUBJECTS & METHODS: Data came from a cross-sectional study of 195 postmenopausal women conducted at the Italian Hospital of Buenos Aires, Argentina. Their sociodemographic, gynecological and clinical characteristics were recorded and sleep was assessed using the Pittsburgh Sleep Quality Index (PSQI), the Epworth Sleepiness Scale (ESS), and the Oviedo Sleep Questionnaire (Cuestionario Oviedo de Sueño, COS). RESULTS: The mean PSQI score was 6.90 ± 4.43. Sleep problems were common, with 46.7% of participants scoring over 5 on the PSQI. Snoring was reported by 13% of the patients (PSQI item 10 A). While 10% of the poor sleepers reported episodes of apnea during rest (PSQI item 10B), 7.1% reported leg spasm (PSQ I item 10C). The mean total COS score was 17.57 ± 7. According to COS item 1, all the subjects reported some dissatisfaction with the quality of their sleep. According to the COS, the prevalence of insomnia was 3.6% using ICD-10 criteria and 15.4% using DSM-IV criteria. The mean ESS score was 6.12 ± 4.09. CONCLUSION: Postmenopausal women are likely to complain of disturbed sleep. Almost half of the women in this survey said their sleep quality was impaired, and most of that group would benefit from medical attention.
Assuntos
Fogachos/epidemiologia , Pós-Menopausa , Distúrbios do Início e da Manutenção do Sono/epidemiologia , Sono , Adulto , Argentina/epidemiologia , Estudos Transversais , Sonhos , Feminino , Nível de Saúde , Humanos , Incidência , Pessoa de Meia-Idade , Prevalência , Síndromes da Apneia do Sono/epidemiologia , Transtornos do Sono-Vigília/epidemiologia , Ronco/epidemiologia , Inquéritos e Questionários , SudoreseRESUMO
The leiomyomas are a common gynecologic entity that may present unusual growth patterns or unusual locations. Its atypical presentations creates a diagnostic challenge. This is a case report of a parasitic leiomyoma located in the anterior abdominal wall in a 53 years old woman with pelvic compressive and urinary symptoms, with no history of any gynecological surgery. This case illustrates the diagnostic difficulties and describes the complementary images used in the preoperative evaluation.
Assuntos
Neoplasias Abdominais/diagnóstico por imagem , Parede Abdominal/diagnóstico por imagem , Leiomioma/diagnóstico por imagem , Segunda Neoplasia Primária/diagnóstico por imagem , Neoplasias Uterinas/diagnóstico por imagem , Útero/diagnóstico por imagem , Neoplasias Abdominais/patologia , Neoplasias Abdominais/fisiopatologia , Neoplasias Abdominais/cirurgia , Parede Abdominal/patologia , Parede Abdominal/cirurgia , Constipação Intestinal/etiologia , Diagnóstico Diferencial , Feminino , Humanos , Histerectomia , Leiomioma/patologia , Leiomioma/fisiopatologia , Leiomioma/cirurgia , Imageamento por Ressonância Magnética , Pessoa de Meia-Idade , Segunda Neoplasia Primária/patologia , Segunda Neoplasia Primária/fisiopatologia , Segunda Neoplasia Primária/cirurgia , Dor Pélvica/etiologia , Salpingectomia , Resultado do Tratamento , Carga Tumoral , Ultrassonografia , Transtornos Urinários/etiologia , Neoplasias Uterinas/patologia , Neoplasias Uterinas/fisiopatologia , Neoplasias Uterinas/cirurgia , Útero/patologia , Útero/cirurgiaAssuntos
Período Pós-Parto , Neoplasias das Glândulas Sudoríparas/patologia , Adenomas Tubulares de Glândulas Sudoríparas/patologia , Neoplasias Vulvares/patologia , Adulto , Feminino , Humanos , Lactação , Gravidez , Complicações Neoplásicas na Gravidez/patologia , Neoplasias das Glândulas Sudoríparas/cirurgia , Adenomas Tubulares de Glândulas Sudoríparas/cirurgia , Neoplasias Vulvares/cirurgiaRESUMO
Early menopause or premature ovarian insufficiency (POI) is a common cause of infertility in women and affects about one per cent of young women. This disorder has significant psychological sequelae and major health implications. Its relevance has increased in recent years due to the fact that age of motherhood is being delayed in developed countries, with the risk of having either primary ovarian insufficiency or less possibilities of pregnancy. The main characteristics are absence of ovulation, amenorrhoea and high levels of serum gonadotropins (hypergonadotropic hypogonadism). Although the aetiology remains uncertain in most cases, several rare specific causes have been elucidated. Potential causes for POI are iatrogenic (ovarian surgery, radiotherapy or chemotherapy), environmental factors, viral infections, metabolic and autoimmune diseases, and genetic alterations. Because of the association with other autoimmune diseases, close follow up is recommended in patients with POI. The traditional indicators to evaluate ovarian ageing are age, serum hormonal levels, anti-Mullerian hormone, antral follicle count, and ultrasonography of ovaries. Hormone replacement therapy remains the mainstay of treatment, and the best chance of achieving a pregnancy is through oocyte donation. This article aims to present an overview of potential causes, clinical manifestations, and treatment options of POI.
Assuntos
Amenorreia/fisiopatologia , Infertilidade Feminina/fisiopatologia , Menopausa Precoce/fisiologia , Insuficiência Ovariana Primária/fisiopatologia , Adulto , Amenorreia/sangue , Feminino , Gonadotropinas/sangue , Humanos , Infertilidade Feminina/sangue , Menopausa Precoce/sangue , Ovulação/sangue , Ovulação/fisiologia , Gravidez , Insuficiência Ovariana Primária/sangue , Saúde da MulherRESUMO
Abnormal uterine bleeding (AUB) is a very common gynecological condition, which may have several causes. A new classification system was recently proposed to standardize the terminology used to describe Abnormal Uterine Bleeding. The International Federation of Gynecology and Obstetrics (FIGO) published guidelines in 2011 to develop universally accepted nomenclature and a classification system. The FIGO classification system (PALM-COEIN) was published to standardize the terminology used in the diagnosis and in investigations into the causes of abnormal uterine bleeding. According to the new FIGO classification, in the absence of structural etiology, the former term "dysfunctional uterine bleeding" should be avoided and clinicians should specify whether AUB is caused by coagulation disorders (AUB-C), ovulation disorder (AUB-O), or endometrial primary dysfunction (AUB-E). This system is based on the pattern and etiology of bleeding and has been adopted by other organizations. Additionally, the American College of Obstetrics and Gynecology (ACOG) has recently updated the recommendations on evaluation of abnormal uterine bleeding and the indications for endometrial biopsies. In short, AUB is a common complaint that can vary from mild to life-threatening if not recognized and treated promptly. In this review, we describe the main causes of abnormal uterine bleeding and summarize the most relevant new guidelines for the diagnosis and management of non-organic abnormal uterine bleeding that comprises AUB-C, AUB-O, AUB-E, AUB-I and AUB-N due to other non-classifiable causes
La hemorragia uterina anormal (HUA) es un trastorno ginecológico muy común, que puede deberse a varias causas. La Federación Internacional de Ginecología y Obstetricia (FIGO) publicó unas directrices en 2011 para establecer una nomenclatura que fuera universalmente aceptada y un sistema de clasificación. El sistema de clasificación de la FIGO (PALM-COEIN) se publicó para intentar estandarizar la terminología que se empleaba en el diagnóstico y en la investigación de las causas de sangrado uterino anormal. Según la nueva clasificación de la FIGO, en ausencia de una patología estructural, debe evitarse el empleo de la antes denominada "hemorragia uterina disfuncional" y los médicos deben indicar si la HUA está ocasionada por trastornos de la coagulación (HUA-C), trastorno de la ovulación (HUA-O), yatrogenia (HUA-I), disfunción primaria del endometrio (AUB-E) o causas no clasificables (HAU-N). Este sistema se basa en el patrón y la etiología de la hemorragia y ha sido adoptado por otras organizaciones. Además, el Colegio Americano de Obstetricia y Ginecología (ACOG) han actualizado recientemente las recomendaciones sobre la evaluación de sangrado uterino anormal, así como las indicaciones para la práctica de biopsias endometriales. En resumen, la HUA es una queja común que puede variar de leve a potencialmente mortal si no se reconoce y trata a tiempo. En esta revisión se describen las principales causas de sangrado uterino anormal y resumimos las nuevas directrices más relevantes para el diagnóstico y el tratamiento del sangrado uterino anormal no orgánico que comprende HUA-C, HUA-O, HUA-E, HUA-I y HUA-N
Assuntos
Humanos , Feminino , Hemorragia Uterina , Transtornos da Coagulação Sanguínea , Endométrio , Ginecologia , Histerectomia , Doença Iatrogênica , ObstetríciaRESUMO
La enfermedad cardiovascular es la principal causa de muerte en mujeres de más de 50 años. Los eventos cardiovasculares son inusuales en mujeres de 55 años, por lo que se ha sugerido que pudiera ser fruto del hipoestrogenismo. En las mujeres hay condiciones únicas que merecen atención especial tales como edad de la menopausia, complicaciones del embarazo (preeclampsia, diabetes y/o hipertensión gestasional,) enfermedades autoinmunes de la colágena como lupus eritematoso y artritis reumatoide. Desafortunadamente la mayoría de los cardiólogos rara vez indagan sobre éstos antecedentes cuando tratan a las mujeres con enfermedad cardiovascular. En esta revisión se abordará el papel que desempeñan las hormonas sexuales esteroideas en el sistema circulatorio así como los factores de riesgo cardiovascular relacionado con las hormonas.
Assuntos
Humanos , Climatério/fisiologia , Doenças Cardiovasculares/diagnóstico , MenopausaRESUMO
La involución del tracto genital femenino refleja su integración con los cambios que sufre el eje hipotálamo-hipofisario-ovárico. El descenso de los niveles de estradiol conlleva una serie de efectos adversos, incluidos los relativos a las vías urinarias inferiores. El cambio más importante es la atrofia vaginal: la mucosa vaginal se vuelve más fina y seca, lo cual puede producir incomodidad vaginal, sequedad, quemazón, prurito y dispareunia. El epitelio vaginal puede presentar cambios inflamatorios y ser un factor que contribuya a los síntomas urinarios, tales como frecuencia, urgencia, disuria, incontinencia, e infecciones recurrentes. Por otra parte, se ha sugerido que los niveles bajos de estrógenos pueden afectar los tejidos periuretrales y contribuir a la laxitud de la pelvis y la incontinencia de esfuerzo. Relacionados con el hipoestrogenismo, los cambios en el pH y la flora vaginal pueden predisponer a las mujeres posmenopáusicas a las infecciones del tracto urinario. La terapia hormonal local en forma de cremas, comprimidos o supositorios es la base del tratamiento de la atrofia genital. Además, otras vías de administración de hormonas, tanto local como sistémica, también han demostrado ser válidas. Sin embargo, a pesar de que los beneficios del reemplazo con estrógenos en la prevención de la atrofia vaginal y la reducción de la incidencia de los síntomas están bien establecidos, este tipo de tratamiento está contraindicado en algunas mujeres y no es una opción aceptable para otras. Pero además, la ruta óptima de administración del tratamiento hormonal, el régimen, las dosis, y las alternativas no hormonales para mejorar los síntomas y la calidad de vida de la población posmenopáusica no han sido completamente estudiados. Esta revisión se centra en los cambios del envejecimiento vaginal e intenta presentar una sinopsis de la fisiopatología y el tratamiento de la atrofia vaginal y la vaginitis atrófica.
Assuntos
Humanos , Feminino , Doenças Urogenitais Femininas/fisiopatologia , Doenças Urogenitais Femininas/terapia , Genitália Feminina/fisiologia , Genitália Feminina/patologia , Vaginite/diagnóstico , Vaginite/terapiaRESUMO
La involución del tracto genital femenino refleja su integración con los cambios que sufre el eje hipotálamo-hipofisario-ovárico. El descenso de los niveles de estradiol conlleva una serie de efectos adversos, incluidos los relativos a las vías urinarias inferiores. El cambio más importante es la atrofia vaginal: la mucosa vaginal se vuelve más fina y seca, lo cual puede producir incomodidad vaginal, sequedad, quemazón, prurito y dispareunia. El epitelio vaginal puede presentar cambios inflamatorios y ser un factor que contribuya a los síntomas urinarios, tales como frecuencia, urgencia, disuria, incontinencia, e infecciones recurrentes. Por otra parte, se ha sugerido que los niveles bajos de estrógenos pueden afectar los tejidos periuretrales y contribuir a la laxitud de la pelvis y la incontinencia de esfuerzo. Relacionados con el hipoestrogenismo, los cambios en el pH y la flora vaginal pueden predisponer a las mujeres posmenopáusicas a las infecciones del tracto urinario. La terapia hormonal local en forma de cremas, comprimidos o supositorios es la base del tratamiento de la atrofia genital. Además, otras vías de administración de hormonas, tanto local como sistémica, también han demostrado ser válidas. Sin embargo, a pesar de que los beneficios del reemplazo con estrógenos en la prevención de la atrofia vaginal y la reducción de la incidencia de los síntomas están bien establecidos, este tipo de tratamiento está contraindicado en algunas mujeres y no es una opción aceptable para otras. Pero además, la ruta óptima de administración del tratamiento hormonal, el régimen, las dosis, y las alternativas no hormonales para mejorar los síntomas y la calidad de vida de la población posmenopáusica no han sido completamente estudiados. Esta revisión se centra en los cambios del envejecimiento vaginal e intenta presentar una sinopsis de la fisiopatología y el tratamiento de la atrofia vaginal y la vaginitis atrófica. (AU)
Assuntos
Humanos , Feminino , Doenças Urogenitais Femininas/fisiopatologia , Doenças Urogenitais Femininas/terapia , Genitália Feminina/patologia , Genitália Feminina/fisiologia , Vaginite/diagnóstico , Vaginite/terapiaRESUMO
El síndrome de Turner (ST) es la anomalía cromosómica más frecuente en mujeres, con una prevalencia de hasta 1/2500 nacidas vivas. El ST es el resultado de la pérdida o anormalidad del segundo cromosoma sexual en, al menos, una línea celular. Estas anomalías estructurales pueden presentarse en estado puro, entre las cuales la monosomía completa 45X0 es la más frecuente...
Assuntos
Doenças Autoimunes , Terapia de Reposição Hormonal , Hipotireoidismo/diagnóstico , Monossomia/diagnóstico , Osteoporose , Síndrome de Turner/epidemiologiaRESUMO
El tratamiento hormonal (TH) produce incrementos en la densidad mineral ósea en todos los lugares del esqueleto. La reducción del riesgo de fractura ha sido documentada por datos de un metaanálisis, estudios de cohortes y el estudio WHI. Los estrógenos son una opción terapéutica para la prevención y el tratamiento de la osteoporosis especialmente en la mujer con síntomas climatéricos, con la consideración de que su uso por tiempo prolongado incrementa los riesgos....
Assuntos
Feminino , Densidade Óssea , Estrogênios/uso terapêutico , Fraturas Ósseas/prevenção & controle , Terapia de Reposição HormonalRESUMO
Objetivo: establecer una relación entre las alteraciones de la glucosa, la insulina, el metabolismo de los lípidos, y los niveles hormonales en relación a la obesidad y la contextura corporal en mujeres con PCOS. Pacientes y métodos: estudio observacional tipo casos-controles, con 223 pacientes diagnosticadas de síndrome de ovarios poliquísticos (SOP) según los criterios de Rotterdam, y 25 controles sanas...
Assuntos
Feminino , Índice de Massa Corporal , LDL-Colesterol/metabolismo , Lipoproteínas LDL/metabolismo , Lipoproteínas LDL/uso terapêutico , Triglicerídeos/análise , Triglicerídeos/metabolismoRESUMO
El fallo ovárico prematuro (FOP) se trata de un trastorno que se manifiesta en forma de amenorrea a una edad precoz, antes de los 40 años, traduciéndose en un cese de la función ovárica, tanto de la función hormonal como genésica. No tan solo hablamos de una causa de esterilidad, sino también de un estado de hipoestrogenismo con sus efectos secundarios...
Assuntos
Feminino , Infertilidade/diagnóstico , Insuficiência Ovariana Primária/epidemiologia , Insuficiência Ovariana Primária/etiologiaRESUMO
Para conocer, diagnosticar, prevenir y tratar la osteoporosis es preceptivo conocer la fisiología del hueso, no sólo como elemento único que permite funciones como el movimiento, sino tambén como sistema, ya que el conjunto del esqueleto supone un elemento vivo y dinámico, determinante en la homeostasis del organismo. Así, el hueso es un tejido conjuntivo que tiene tres funciones principales...
Assuntos
Humanos , Glicoproteínas/administração & dosagem , Osteoblastos , Osteoporose/complicações , Osteoporose/fisiopatologia , Proteoglicanas/administração & dosagemRESUMO
AIM: To analyse the effect of a specific program of weight training exercise with closed kinetic chain in bone mineral density in postmenopausal women with osteopenia or osteoporosis. METHODS: A total of 59 postmenopausal women with osteoporosis or osteopenia were included in this prospective study. Subjects were divided into two groups: the study group (SG, n = 30; 57.5 + or - 5.1 years) and the control group (CG, n = 29; 56.6 + or - 4.6 years). In the study group was applied a weight exercise protocol (longitudinal forces in closed kinetic chain) during 12 months, whereas in the control group no weight exercise protocol was applied. Bone mineral density at the lumbar spine and hip was assessed at baseline and at the end of follow-up by dual energy X-ray absorptiometry. RESULTS. Although no significant intragroup differences were found, patients in SG showed a 1.17% increase in the lumbar spine whereas in CG a 2.26% decrease in bone density was detected. CONCLUSION: This protocol of weight training exercise did not significantly improve bone mineral density in postmenopausal women with osteopenia or osteoporosis, but in comparison to the control group, the results showed the importance of practising the specific exercise program for maintenance of bone health in postmenopausal women.
Assuntos
Densidade Óssea/fisiologia , Doenças Ósseas Metabólicas/terapia , Terapia por Exercício , Pós-Menopausa , Idoso , Doenças Ósseas Metabólicas/patologia , Feminino , Quadril/patologia , Humanos , Pessoa de Meia-Idade , Estudos Prospectivos , Treinamento Resistido , Coluna Vertebral/patologia , Estatísticas não Paramétricas , Resultado do TratamentoRESUMO
Los trastornos por ansiedad y las alteraciones del sueño, representan un problema de salud de una alta incidencia y un importante efecto potencial en la calidad de vida de la población, especialmente en los países económicamente desarrollados. Ante este tipo de cuadros clínicos, es fundamental en todos los casos la valoración por parte de un especialista, para descartar la existencia de una patología orgánica y/o psiquiátrica de base.
Assuntos
Adulto , Passiflora/efeitos adversos , Valeriana/efeitos adversosRESUMO
El conocimiento de los beneficios y los riesgos de un tratamiento es fundamental para determinar la conveniencia o no de su instauración. Hablar de riesgos y beneficios de cualquier tratamiento suele se dificil y más en el caso de la terapia hormonal sustitutiva (THS), ya que se han utilizado multitud de fármacos, vías y pautas y los datos obtenidos con las diferentes terapeúticas...